Citation Impact
Citing Papers
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
2010 Standout
The effects of oxidative stress on female reproduction: a review
2012 Standout
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies
2016 Standout
Nutraceuticals: Facts and fiction
2007 Standout
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
2005 Standout
Endometriosis
2009 Standout
Cushing's syndrome
2015 Standout
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
Stress-related Disturbances of the Menstrual Cycle
1997
Psychogenic Infertility—Myths and Facts
2003 Standout
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
2002 Standout
Treatment of endometriosis with the antiprogesterone mifepristone (RU486)
1996
Restrained eating and ovulatory disturbances: possible implications for bone health
1994
Aromatase inhibitors in ovarian stimulation
2007
The biology of VEGF and its receptors
2003 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Dietary phenolics: chemistry, bioavailability and effects on health
2009 Standout
Physiological role and clinical utility of inositols in polycystic ovary syndrome
2016
Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies
2005
2-Hydroxyestradiol Attenuates Renal Disease in Chronic Puromycin Aminonucleoside Nephropathy
2002
Antioxidants to enhance fertility: Role of eNOS and potential benefits
2011
Abdominal Adhesiolysis: Inpatient Care and Expenditures in the United States in 1994
1998
Mifepristone (RU486): A review
1997
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Timing of Pubertal Maturation in Girls: An Integrated Life History Approach.
2004 Standout
How were new medicines discovered?
2011 Standout
Executive summary of the Stages of Reproductive Aging Workshop + 10
2012 Standout
Dietary Restraint and Telomere Length in Pre- and Postmenopausal Women
2008 StandoutNobel
Adhesions after extensive gynecologic surgery: Clinical significance, etiology, and prevention
1994
Recurrence of endometriosis and its control
2009
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study
1999 Standout
Short-Term Administration of Antivascular Endothelial Growth Factor Antibody in the Late Follicular Phase Delays Follicular Development in the Rhesus Monkey1
2001
Endometriosis: pathogenesis and treatment
2013 Standout
Age-Related Analysis of Inhibin A, Inhibin B, and Activin A Relative to the Intercycle Monotropic Follicle-Stimulating Hormone Rise in Normal Ovulatory Women
2004
Derivation of Functional Antagonists Using N-Terminal Extracellular Domain of Gonadotropin and Thyrotropin Receptors
1997 StandoutNobel
Polycystic ovary syndrome
2016 Standout
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Reflections on inositol(s) for PCOS therapy: steps toward success
2015
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Stress and the Reproductive Cycle
1999
The Complex Role of Estrogens in Inflammation
2007 Standout
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
2012
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Pycnogenol® in Chronic Venous Insufficiency and Related Venous Disorders
2013
Polyphenol composition and in vitro antioxidant activity of amaranth, quinoa buckwheat and wheat as affected by sprouting and baking
2009 Standout
Peritoneal Adhesions: Etiology, Pathophysiology, and Clinical Significance
2001 Standout
The Reciprocal Interactions between Polyphenols and Gut Microbiota and Effects on Bioaccessibility
2016 Standout
Estradiol Therapy Combined With Progesterone and Endothelium-Dependent Vasodilation in Postmenopausal Women
1998
Phenolic compounds in plants and agri-industrial by-products: Antioxidant activity, occurrence, and potential uses
2005 Standout
Short-Term Administration of Antivascular Endothelial Growth Factor Antibody in the Late Follicular Phase Delays Follicular Development in the Rhesus Monkey
2001
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences*
1997
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
2017
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Stress and the Reproductive Cycle
1999
Menstrual Abnormalities in Women with Cushing’s Disease Are Correlated with Hypercortisolemia Rather Than Raised Circulating Androgen Levels
1998
Estradiol With or Without Progesterone and Ambulatory Blood Pressure in Postmenopausal Women
1999
Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular Mechanisms and Experimental Models
2014 Standout
Hesperidin attenuates benzo[α] pyrene-induced testicular toxicity in rats via regulation of oxidant/antioxidant balance
2009
Works of Scott Roseff being referenced
Dynamic Changes in Circulating Inhibin Levels during the Luteal-Follicular Transition of the Human Menstrual Cycle *
1989
Laparoscopy in the Diagnosis and Therapy of Chronic Pelvic Pain
1990
The D-chiro-inositol paradox in the ovary
2011
Follicular Arrest during the Midfollicular Phase of the Menstrual Cycle: A Gonadotropin-Releasing Hormone Antagonist Imposed Follicular-Follicular Transition*
1991
Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome.
1993
Effect of human corticotropin-releasing hormone on gonadotropin secretion in cycling and postmenopausal women
1992
Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
2011
Improvement in sperm quality and function with French maritime pine tree bark extract.
2002
Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome
1993
Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women
1990